The Patent Finder

Nogra Pharma Limited

Also on record
Records under this name other than the patents Nogra Pharma Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 21 patents it holds.

Back to Nogra Pharma Limited

PatentTitleStatus Expires Confidence
US 9,133,099Compounds and Their Salts Specific to the Ppar Receptors and the Egf Receptors and Their Use in the Medical Field
Term ended
Term ended Jul 24, 2026 · Medium confidence
Term endedTerm ended Jul 24, 2026Medium confidence
US 9,345,680Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field
Term ended
Ended no later than Jul 24, 2026 · From the USPTO record
Term endedEnded no later than Jul 24, 2026From the USPTO record
US 9,561,202Compounds and their Salts Specific to the PPAR Receptors and the EGF Receptors and their Use in the Medical Field
Term ended
Term ended Jul 24, 2026 · High confidence
Term endedTerm ended Jul 24, 2026High confidence
US 10,016,381Compounds and Their Salts Specific to the Ppar Receptors and the Egf Receptors and Their Use in the Medical Field
Lapsed on the fee record
Ended Jul 10, 2026 · Medium confidence
Lapsed on the fee recordEnded Jul 10, 2026Medium confidence
US 8,710,100Compounds and Their Salts Specific to the Ppar Receptors and the Egf Receptors and Their Use in the Medical Field
Formerly held
Lapsed on the fee record
Ended Apr 29, 2026 · Medium confidence
Lapsed on the fee recordEnded Apr 29, 2026Medium confidence
US 9,913,817Methods for preventing or reducing colon carcinogenesis
Lapsed on the fee record
Ended Mar 13, 2026 · From the USPTO record
Lapsed on the fee recordEnded Mar 13, 2026From the USPTO record
US 11,162,097Methods of Treating Intestinal Fibrosis Using SMAD7 Inhibition
Formerly held
Lapsed on the fee record
Ended Nov 2, 2025 · High confidence
Lapsed on the fee recordEnded Nov 2, 2025High confidence
US 9,682,050Methods of treating lactose intolerance
Lapsed on the fee record
Ended Jun 20, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jun 20, 2025From the USPTO record
US 10,959,970Methods of treating hair related conditions
Lapsed on the fee record
Ended Mar 30, 2025 · From the USPTO record
Lapsed on the fee recordEnded Mar 30, 2025From the USPTO record
US 8,153,693Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
Lapsed on the fee record
Ended Apr 10, 2024 · From the USPTO record
Lapsed on the fee recordEnded Apr 10, 2024From the USPTO record
10 of 42 patents shown.
Pro members see all 42.
Pro members: see all 42 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited